Veterinary Renal Disease Market Forecast 2026–2035: How to Leverage Market Growth

January 29, 2026January 29, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the long-chain polyamide market from 2026–2035 with trusted insights from The Business Research Company

Across 2026–2030, what is the expected market valuation path of the Veterinary Renal Disease Market?

The veterinary renal disease market has experienced strong expansion in recent years. This market is projected to grow from $16.59 billion in 2025 to $17.73 billion in 2026, at a compound annual growth rate (CAGR) of 6.9%. The historical development of this market is attributable to an aging pet population, the late diagnosis of renal disorders in animals, limited availability of advanced renal treatments, an increasing incidence of dehydration and infections, and a reliance on symptomatic treatment approaches.

The veterinary renal disease market is projected to experience substantial expansion over the upcoming years. It is anticipated to reach $22.42 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.0%. This projected growth during the forecast period can be primarily attributed to several factors, including enhanced renal diagnostics and imaging technologies, an increased uptake of preventive screening initiatives, the creation of specific renal medications, improved access to veterinary dialysis services, and heightened understanding regarding the management of chronic kidney disease. Key trends anticipated during this period encompass the growing incidence of chronic kidney disease among companion animals, a greater emphasis on early detection and regular renal screenings, the increasing implementation of long-term renal management strategies, the broadening of specialized renal treatment and dialysis options, and a reinforced focus on nutritional and supportive interventions for optimal renal health.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15957&type=smp

Which Drivers Are Supporting The Rise Of The Veterinary Renal Disease Market?

Growing pet ownership is anticipated to propel the veterinary renal disease market’s expansion moving forward. Veterinary renal disease pertains to conditions affecting animal kidneys, resulting in impaired kidney function and potentially leading to symptoms such as heightened thirst, frequent urination, loss of appetite, and weight reduction. The increasing incidence of veterinary renal disease is influenced by longer pet lifespans, exposure to environmental toxins, dietary elements, and genetic predispositions. Treatments for veterinary renal disease in pets typically involve dietary management, medication, and fluid therapy to alleviate symptoms, slow disease progression, and enhance quality of life. For instance, in April 2025, according to the Canadian Animal Health Institute, a Canada-based trade association, in 2024, Canada was home to an estimated 7.2 million dogs and 8.2 million cats, making pets an integral part of more than half of Canadian households. Therefore, the rise in pet ownership is driving the growth of the veterinary renal disease market.

What Segments Are Identified Within The Structure Of The Veterinary Renal Disease Market?

The veterinary renal disease market covered in this report is segmented –

1) By Type: Diagnosis, Treatment

2) By Animal Type: Canine, Feline, Bovine, Equine, Other Animal Types

3) By Indication: Renal Failure, Chronic Kidney Disease (Ckd), Renal Cystitis, Kidney Stones, Nephritis, Other Indications

4) By Route Of Administration: Injectable, Oral

5) By Distribution Channel: Pharmacies, Pet Specialty Stores, E-Commerce, Other Distribution Channels

Subsegments:

1) By Diagnosis: Blood Tests, Urine Tests, Imaging, Biopsy

2) By Treatment: Medications, Dialysis, Kidney Transplantation, Fluid Therapy

What Trends Are Expected To Impact The Competitive Landscape Of The Veterinary Renal Disease Market?

Major companies active in the veterinary renal disease market are concentrating on implementing technical improvements in both treatment and diagnostic procedures. This encompasses the development of new diagnostic tests capable of identifying kidney injury even when no clinical signs are evident. These diagnostic tests are designed to detect subtle modifications in renal function or structure, thereby facilitating early intervention to prevent the advancement of renal dysfunction. For instance, in June 2023, IDEXX Laboratories Inc., a US-based developer and manufacturer of veterinary products and services, introduced the first veterinary diagnostic test specifically for detecting kidney injury in cats and dogs. This particular test, known as the IDEXX Cystatin B Test, is engineered to help veterinarians pinpoint kidney injury before any changes in kidney function become apparent, ultimately leading to enhanced patient outcomes. The IDEXX Cystatin B Test will be integrated into test panels used for evaluating renal health, offering valuable insights during an estimated two million patient visits annually.

Which Major Firms Are Strengthening Their Position In The Veterinary Renal Disease Market?

Major companies operating in the veterinary renal disease market are Bayer HealthCare Animal Health Inc., Nestlé Purina PetCare Company, Zoetis Inc., Boehringer Ingelheim, Covetrus Inc., Elanco Animal Health Incorporated, Hill’s Pet Nutrition Inc., IDEXX Laboratories Inc., Ceva Santé Animale S.A., Dechra Pharmaceuticals PLC, Neogen Corporation, Vetoquinol S.A., Norbrook Laboratories Limited, Nutramax Laboratories Veterinary Sciences Inc., Animalcare Group plc, Antech Diagnostics Inc., Kindred Biosciences Inc., Vedco Inc., MSD Animal Health, Veterinary Transplant Services Inc., Kibow Biotech Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/veterinary-renal-disease-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Veterinary Renal Disease Market?

North America was the largest region in the veterinary renal disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary renal disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Veterinary Renal Disease Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15957&type=smp

Browse Through More Reports Similar to the Global Veterinary Renal Disease Market 2026, By The Business Research Company

Kidney Disease Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/kidney-disease-global-market-report

Veterinary Infectious Disease Diagnostics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-infectious-disease-diagnostics-global-market-report

Veterinary Healthcare Market 2026

https://www.thebusinessresearchcompany.com/report/veterinary-healthcare-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795